en

High-throughput antibody screening of patients suspected of COVID-19 infection

High-throughput antibody screening of patients suspected of COVID-19 infection

Vitrotest® SARS–CoV-2 Total Ab – new ELISA test-kit for the simultaneous detection of specific antibodies (IgM, IgA, IgG) to SARS-CoV-2, user friendly one-step ELISA sandwich without preliminary dilution of the samples. It is a highly sensitive and specific test lasting 60 minutes.
Kit was carefully researched in Europe on standard panels and clinical material. The sensitivity and specificity Vitrotest® SARS-CoV-2 Total Ab test kit on the verification panel "Verification Panel for Serology Assays code: 20 / B770" (produced by NIBSC, UK) made up 100%.
Test specificity on 528 blood sera samples obtained during the first half of 2019 (before the start of COVID-19 pandemic) made up 99,2%.
The sensitivity of Vitrotest® SARS-CoV-2 Total Ab was evaluated on 1117 human sera samples with COVID-19 diagnosis in the early stages of infection (the first-second week of symptoms), the specific antibodies were detected in 96% samples.